G2TT
来源类型Working Paper
规范类型报告
DOI10.3386/w17226
来源IDWorking Paper 17226
Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets
Patricia M. Danzon; Michael F. Furukawa
发表日期2011-07-20
出版年2011
语种英语
摘要This paper examines the role of regulation and competition in generic markets. Generics offer large potential savings to payers and consumers of pharmaceuticals. Whether the potential savings are realized depends on the extent of generic entry and uptake and the level of generic prices. In the U.S., the regulatory, legal and incentive structures encourage prompt entry, aggressive price competition and patient switching to generics. Key features are that pharmacists are authorized and incentivized to switch patients to cheap generics. By contrast, in many other high and middle income countries, generics traditionally competed on brand rather than price because physicians rather than pharmacies are the decision-makers. Physician-driven generic markets tend to have higher generic prices and may have lower generic uptake, depending on regulations and incentives.
主题Health, Education, and Welfare ; Health ; Other ; Law and Economics ; Industrial Organization ; Regulatory Economics ; Industry Studies
URLhttps://www.nber.org/papers/w17226
来源智库National Bureau of Economic Research (United States)
引用统计
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/574904
推荐引用方式
GB/T 7714
Patricia M. Danzon,Michael F. Furukawa. Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets. 2011.
条目包含的文件
文件名称/大小 资源类型 版本类型 开放类型 使用许可
w17226.pdf(371KB)智库出版物 限制开放CC BY-NC-SA浏览
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Patricia M. Danzon]的文章
[Michael F. Furukawa]的文章
百度学术
百度学术中相似的文章
[Patricia M. Danzon]的文章
[Michael F. Furukawa]的文章
必应学术
必应学术中相似的文章
[Patricia M. Danzon]的文章
[Michael F. Furukawa]的文章
相关权益政策
暂无数据
收藏/分享
文件名: w17226.pdf
格式: Adobe PDF
此文件暂不支持浏览

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。